WO2023104788 - REACTIVE ALDEHYDE BIOMARKERS OF TYPE 2 DIABETES AND DIABETIC NEPHROPATHY
National phase entry:
Publication Number
WO/2023/104788
Publication Date
15.06.2023
International Application No.
PCT/EP2022/084582
International Filing Date
06.12.2022
Title **
[English]
REACTIVE ALDEHYDE BIOMARKERS OF TYPE 2 DIABETES AND DIABETIC NEPHROPATHY
[French]
BIOMARQUEURS ALDÉHYDES RÉACTIFS DU DIABÈTE DE TYPE 2 ET DE LA NÉPHROPATHIE DIABÉTIQUE
Applicants **
RANDOX LABORATORIES LTD
Ardmore
55 Diamond Road
Crumlin, Antrim BT29 4QY, GB
Inventors
COBICE, Diego
Ulster University
Cromore Road
Coleraine, Antrim BT52 1SA, GB
MOORE, Tara
Ulster University
Cromore Road
Coleraine, Antrim BT52 1SA, GB
FITZGERALD, Peter
55 Diamond Road
Crumlin, Antrim BT29 4QY, GB
RUDDOCK, Mark
55 Diamond Road
Crumlin, Antrim BT29 4QY, GB
BROCKBANK, Simon
55 Diamond Road
Crumlin, Antrim BT29 4QY, GB
HARKIN, Carla
Ulster University
Cromore Road
Coleraine, Antrim BT52 1SA, GB
Priority Data
2117622.7
07.12.2021
GB
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 961 | |
| EPO | Filing, Examination | 4598 | |
| Japan | Filing | 592 | |
| South Korea | Filing | 574 | |
| USA | Filing, Examination | 2710 |
Total: 9435 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
Methods of diagnosing type 2 diabetes mellitus and diabetic nephropathy are described that make use of reactive aldehyde species.[French]
L'invention concerne des méthodes de diagnostic du diabète sucré de type 2 et de la néphropathie diabétique qui utilisent des espèces d'aldéhydes réactifs.